How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Adbry cost savings if eligible
If you are eligible to receive your Adbry prescription through the patient assistance program, your medication will be free. We charge a flat monthly service fee of $49 per medication to cover the cost of our services.
Am I eligible for Adbry patient assistance?
To be eligible for the Adbry patient assistance program, you will need to meet specific eligibility criteria set by the pharmaceutical company. At NiceRx, we review each Adbry enrollment application individually. The main factors considered are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Adbry patient assistance program?
Applying for the Adbry patient assistance program through NiceRx is simple. Begin by completing the enrollment application on our website. We will ask for details about your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers that supply your medication. We may be able to help you access patient assistance for other medications as well as Adbry, so please tell us about any medications that you have been prescribed.
If we determine that you may be eligible for Adbry assistance, we will handle the full enrollment process on your behalf. We will work with your healthcare provider to prepare and submit all the documents required for you to enroll. If you are successfully enrolled in the Adbry patient assistance program, we will also request your Adbry medication refills on your behalf for up to 1 year. At the end of your enrollment period, we will contact you for updated details and seek to re-enroll you in the program.
Is NiceRx an Adbry coupon provider?
NiceRx does not provide Adbry coupons, discount cards or copay cards. We do not offer printable Adbry manufacturer coupons, Adbry discounts, rebates, Adbry savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your Adbry medication with NiceRx.
Can NiceRx help me get Adbry cheaper if I have insurance?
NiceRx may be able to help you access Adbry patient assistance if:
- You have a high copay or coinsurance responsibility for Adbry
- Your insurance company will not pay for your Adbry prescription
- You do not have insurance
Complete your enrollment application online to find out more.
How much does Adbry cost without insurance?
Adbry prices without insurance will vary by retailer. As a guide, Adbry subcutaneous solution (ldrm 150mg/mL) will typically cost around $1,800 for 2 milliliters.
How much does Adbry cost with insurance?
Your individual healthcare plan will determine the copay of Adbry with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.
What is Adbry?
Adbry is an FDA (U.S. Food and Drug Administration) approved medication manufactured by LEO Pharma A/S. FDA approval for Adbry is based on efficacy and safety results from the ECZTRA 1, Ecztra 2, and ECZTRA 3 phase 3 clinical trials.
Adbry is an interleukin-13 antagonist for the treatment of moderate-to-severe atopic dermatitis (eczema) in adult patients whose disease is not controlled well enough with topical therapies or when those therapies are not recommended. Adbry specifically targets and inhibits IL-13 cytokines in the body and can be used as monotherapy or with topical corticosteroids (TCS).
What doses of Adbry are available?
Adbry is available in injection form, in the following doses: 150 mg/mL solution in a single-dose prefilled syringe.
Before beginning treatment with Adbry complete all vaccinations as recommended by current immunization guidelines. The recommended initial dose of Adbry is 600 mg (four 150 mg injections), followed by 300 mg (two 150 mg injections) given every other week. A dosage of 300 mg every 4 weeks may be used for patients weighing less than 100 kg who have achieved clear or almost clear skin after 16 weeks of treatment.
Please read the prescribing information and patient information for the instructions for use and always speak with your healthcare provider for medical advice about any changes to your dose so they can monitor and evaluate your condition.
Adbry active ingredients
Adbry contains tralokinumab-ldrm, a biologic drug, as the active ingredient.
Adbry side effects
The most common side effects of Adbry in clinical trials compared to placebo (incidence ≥ 1%) include:
- Upper respiratory tract infections
- Conjunctivitis and keratitis
- Injection site reactions
In rare instances, Adbry can cause more serious adverse effects. These can include:
- Hypersensitivity reactions, including anaphylaxis, and angioedema
- Parasitic (Helminth) infections
- Risk of infection with Live Vaccines
Your doctor will assess the benefits of using Adbry against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Adbry to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Adbry drug interactions
Other drugs may interact with Adbry, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medication including any supplements you are taking.
You should not use Adbry if you:
- Are allergic to the active ingredient tralokinumab-ldrm
- Have a known hypersensitivity to tralokinumab-ldrm or to any of the other ingredients in Adbry
Talk to your doctor about your medical conditions before using Adbry if you:
- Are taking any of the medications that could interact with Adbry
- Have eye problems
- Have a parasitic (helminth) infection
- Are due to receive any vaccinations
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Adbry is the trademark brand name for tralokinumab-ldrm manufactured by LEO Pharma A/S and distributed by Leo Pharma Inc., Madison. A generic version of tralokinumab-ldrm is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Adbry savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.